Adverse drug reactions
A unfavourable or harmful reaction that follows the use of a medication or medication combination in normal conditions and is believed to be brought on by the medication is known as an adverse drug reaction. A negative reaction typically necessitates stopping the medicine or reducing the dose. Any injury that occurs to a patient while they are taking medicine, whether or not the medication is regarded to be the cause, is considered an adverse event.
Related Conference of Adverse drug reactions
September 15-16, 2025
29th International Conference on Neuropharmacology and Neurochemistry
Bangkok, Thailand
September 22-23, 2025
5th International Conference on Biomedicine & Pharmacotherapy
Amsterdam, Netherlands
Adverse drug reactions Conference Speakers
Recommended Sessions
- Pharmacology
- Adverse drug reactions
- Autonomic Pharmacology
- Cardiovascular Pharmacology
- Clinical Pharmacology
- Drug Discovery and Drug Screening
- Environmental Pharmacology
- Ethnopharmacology
- Forensic Toxicology
- Genetic Toxicology
- Neuropharmacology
- Nursing Pharmacology
- Pharmaceutical Chemistry
- Pharmacodynamics
- Pharmacokinetics
- Pharmacological Testing
- Psychopharmacology
- Toxicology
Related Journals
Are you interested in
- Advanced Diagnostics & Biomarkers - PHARMACY CONGRESS 2025 (Italy)
- Advanced Drug Delivery Systems - PHARMACY CONGRESS 2025 (Italy)
- Advanced Drug Delivery Systems - BIOMEDICINE 2025 (Netherlands)
- Advances in Omics Technologies - BIOMEDICINE 2025 (Netherlands)
- Advances in Pain Management - PHARMACY CONGRESS 2025 (Italy)
- Advances in Vaccine Technology - BIOMEDICINE 2025 (Netherlands)
- Alzheimer’s and Parkinson’s Diseases - Neuropharmaceutics 2025 (Thailand)
- Antimicrobial Therapy & Resistance - PHARMACY CONGRESS 2025 (Italy)
- Artificial Intelligence in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Biologics & Biosimilars - PHARMACY CONGRESS 2025 (Italy)
- Biotechnology in Drug Development - BIOMEDICINE 2025 (Netherlands)
- Brain Injury and Behavioral Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Brain Pathology and Oncology Research - Neuropharmaceutics 2025 (Thailand)
- Brain Stimulation and Imaging - Neuropharmaceutics 2025 (Thailand)
- Brain Structure and Function - Neuropharmaceutics 2025 (Thailand)
- Cardiovascular Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Case Reports: Unusual Adverse Drug Reactions - PHARMACY CONGRESS 2025 (Italy)
- Clinical Neurophysiology and Stroke - Neuropharmaceutics 2025 (Thailand)
- Clinical Pharmacology and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Clinical Trials for Rare Diseases - PHARMACY CONGRESS 2025 (Italy)
- CNS and Brain Disorders - Neuropharmaceutics 2025 (Thailand)
- Cognitive Neuroscience and Psychology - Neuropharmaceutics 2025 (Thailand)
- Cutting-Edge Formulation Strategies - PHARMACY CONGRESS 2025 (Italy)
- Digital Health and Telemedicine - BIOMEDICINE 2025 (Netherlands)
- Digital Health Technologies Integration - PHARMACY CONGRESS 2025 (Italy)
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals - BIOMEDICINE 2025 (Netherlands)
- Gene Therapy and Genetic Medicine - BIOMEDICINE 2025 (Netherlands)
- Human Brain Mapping - Neuropharmaceutics 2025 (Thailand)
- Immunotherapy and Immunopharmacology - BIOMEDICINE 2025 (Netherlands)
- Infectious Diseases and Antimicrobial Resistance - BIOMEDICINE 2025 (Netherlands)
- Innovations in Biologics and Biosimilars - BIOMEDICINE 2025 (Netherlands)
- Innovations in Clinical Trials - PHARMACY CONGRESS 2025 (Italy)
- Metabolic Disorders and Endocrinology - BIOMEDICINE 2025 (Netherlands)
- Molecular and cellular neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Nanotechnology in Biomedicine - BIOMEDICINE 2025 (Netherlands)
- Neurobiology and Behaviors - Neuropharmaceutics 2025 (Thailand)
- Neurogenesis - Neuropharmaceutics 2025 (Thailand)
- Neuroimmunology and Neurological Infections - Neuropharmaceutics 2025 (Thailand)
- Neuroinformatics and Computational Neuroscience - Neuropharmaceutics 2025 (Thailand)
- Neurological Disorders and Stroke - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and genetic aspects of CNS function - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurochemistry - Neuropharmaceutics 2025 (Thailand)
- Neuropharmacology and Neurotherapeutics - BIOMEDICINE 2025 (Netherlands)
- Neurorehabilitation and Neural Repair - Neuropharmaceutics 2025 (Thailand)
- Neuroscience and Artificial Intelligence - Neuropharmaceutics 2025 (Thailand)
- Neurotherapeutics and Case Studies - Neuropharmaceutics 2025 (Thailand)
- Nutraceuticals & Herbal Medicines - PHARMACY CONGRESS 2025 (Italy)
- Oncology Research and Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Paediatric & Geriatric Pharmaceutical Innovations - PHARMACY CONGRESS 2025 (Italy)
- Paediatric and Geriatric Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Pharmaceutical Biotechnology - PHARMACY CONGRESS 2025 (Italy)
- Pharmaceutical Ethics & Compliance - PHARMACY CONGRESS 2025 (Italy)
- Pharmaceutical Policy & Health Economics - PHARMACY CONGRESS 2025 (Italy)
- Pharmacogenomics & Personalized Medicine - PHARMACY CONGRESS 2025 (Italy)
- Pharmacogenomics and Personalized Medicine - BIOMEDICINE 2025 (Netherlands)
- Pharmacological Interventions for Mental Health - PHARMACY CONGRESS 2025 (Italy)
- Pharmacovigilance & Drug Safety - PHARMACY CONGRESS 2025 (Italy)
- Pharmacovigilance and Drug Safety - BIOMEDICINE 2025 (Netherlands)
- Pharmacy Informatics - PHARMACY CONGRESS 2025 (Italy)
- Pre- and post-synaptic function - Neuropharmaceutics 2025 (Thailand)
- Public Health and Pharmacoeconomics - BIOMEDICINE 2025 (Netherlands)
- Rare and Orphan Diseases: Therapeutic Approaches - BIOMEDICINE 2025 (Netherlands)
- Rare Disease Therapeutics - BIOMEDICINE 2025 (Netherlands)
- Regenerative Medicine and Tissue Engineering - BIOMEDICINE 2025 (Netherlands)
- Regulatory Affairs & Drug Approval - PHARMACY CONGRESS 2025 (Italy)
- Respiratory and Pulmonary Pharmacotherapy - BIOMEDICINE 2025 (Netherlands)
- Stem Cells Role in Neuro-Biological Treatment - Neuropharmaceutics 2025 (Thailand)
- Synapse formation and neurotransmitter receptors - Neuropharmaceutics 2025 (Thailand)
- Synaptic Function and Dysfunction in Brain Diseases - Neuropharmaceutics 2025 (Thailand)
- Synaptic plasticity and memory - Neuropharmaceutics 2025 (Thailand)